Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00466037
Status:
TERMINATED
Last Update Posted:
2007-04-27
First Post:
2007-04-24
Brief Title:
The Effect of Rituximab on the Humoral Response to Influenza Vaccine
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Tel-Aviv Sourasky Medical Center
Organization Data
Organization:
Tel-Aviv Sourasky Medical Center
Class:
OTHER_GOV
Study ID:
TASMC-05-OE-204-CTIL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None